Inhibition of the antibody production by acetaminophen independent of liver injury in mice

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 2, 2002, Pages 201-205

  Yamaura, Katsunori ^a   Ogawa, Kohei ^a   Yonekawa, Taeko ^a   Nakamura, Tomonori ^a   Yano, Shingo ^a   Ueno, Koichi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Acetaminophen; Alanine transaminase (ALT); Antibody production; Hepatotoxicity; Immune suppression; Mice

Indexed keywords

AMINOTRANSFERASE; CONCANAVALIN A; LIPOPOLYSACCHARIDE; PARACETAMOL; ANALGESIC AGENT;

ANTIBODY PRODUCING CELL; ANTIBODY PRODUCTION; ARTICLE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVITY; LIVER INJURY; LIVER TOXICITY; MOUSE; NONHUMAN; PROTEIN SYNTHESIS INHIBITION; SINGLE DRUG DOSE; SPLEEN CELL; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; T LYMPHOCYTE; TOXIC HEPATITIS;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; ANTIBODY FORMATION; CELL SURVIVAL; FEMALE; FLOW CYTOMETRY; HEPATITIS, TOXIC; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES;

EID: 0036482240     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.201     Document Type: Article

References (44)

1. Lesko S. M., Mitchell A. A., Pediatrics (Online), 104, e39 (1999).
2. Niederhoff H., Zahradnik H. P., Am. J. Med., 75, 117-120 (1983).
3. Rudolph A. M., Arch. Intern. Med., 141, 358-363 (1981).
4. Jollow D. J., Thorgeirsson S. S., Potter W. Z., Hashimoto M., Mitchell J. R., Pharmacology, 12, 251-271 (1974).
5. Brent J., Rumack B., Clin. Toxicol., 31, 173-196 (1993).
6. Brent J., Rumack B., Clin. Toxical., 31, 139-171 (1993).
7. Mitchell J. R., Jollow D. J., Potter W. Z., Davis D. C., Gillette J. R., Brodie B. B., J. Pharmacol. Exp. Ther., 187, 185-194 (1973).
8. Dahlin D. C., Miwa G. T., Lu A. Y., Nelson S. D., Proc. Natl. Acad. Sci. U.S.A., 81, 1327-1331 (1984).
9. Patten C. J., Thomas P. E., Guy R. L., Lee M., Gonzalez F. J., Guengerich F. P., Yang C. S., Chem. Res. Toxicol., 6, 511-518 (1993).
10. Raucy J. L., Lasker J. M., Lieber C. S., Black M., Arch. Biochem. Biophys., 271, 270-283 (1989).
11. Lee S. S., Buters J. T., Pineau T., Fernandez-Salguero P., Gonzalez F. J., J. Biol. Chem., 271, 12063-12067 (1996).
12. McMurtry R. J., Snodgrass W. R., Mitchell J. R., Toxicol. Appl. Pharmacol., 46, 87-100 (1978).
13. Prescott L. F., Park J., Ballantyne A., Adriaenssens P., Proudfoot A. T., Lancet, 27, 432-434 (1977).
14. Smilkstein M. J., Knapp G. L., Kulig K. W., Rumack B. H., N. Engl. J. Med., 319, 1557-1562 (1988).
15. Wendel A., Feuerstein S., Konz K. H., Biochem. Pharmacol., 28, 2051-2055 (1979).
16. Strubelt O., Dost-Kempf E., Siegers C. P., Younes M., Volpel M., Preuss U., Dreckmann J. G., Toxicol. Appl. Pharmacol., 60, 66-77 (1981).
17. Igarashi T., Satoh T., Ueno K., Kitagawa H., J. Pharmacobio-Dyn., 6, 941-949 (1983).
18. Hinson J. A., Mays J. B., Cameron A. M., Biochem. Pharmacol., 32, 1979-1988 (1983).
19. Pessayre D., Dolder A., Artigou J. Y., Wandscheer J. C., Descatoire V., Degott C., Benhamou J. P., Gastroenterology, 77, 264-271 (1979).
20. Kaminski N. E., Barnes D. W., Jordan S. D., Holsapple M. P., Toxicol. Appl. Pharmacol., 102, 9-20 (1990).
21. Lie T. S., Nakajima Y., Hofer M., Lee K. S., Otani Y., Nakano H., Res. Exp. Med., 187, 195-201 (1987).
22. Johnson K. W., Munson A. E., Kim D. H., Holsapple M. P., J. Pharmacol. Exp. Ther., 240, 847-855 (1987).
23. Kaminski N. E., Jordan S. D., Holsapple M. P., Fundam. Appl. Toxicol., 12, 117-128 (1989).
24. Ueno K., Yamaura K., Nakamura T., Satoh T., Yano S., Res. Commun. Mol. Pathol. Pharmacol., In press (2001).
25. Lippi U., Guidi G., Clin. Chim. Acta., 28, 431-437 (1970).
26. Jerne N. K., Nordin A. A., Science, 140, 405 (1963).
27. Goodwin C. J., Holt S. J., Downes S., Marshall N. J., J. Immunol. Methods., 179, 95-103 (1995).
28. Price V. F., Miller M. G., Jollow D. J., Biochem. Pharmacol., 36, 427-433 (1987).
29. Di Simplicio P., Rossi R., Falcinelli S., Ceserani R., Formento M. L., Eur. J. Appl. Physiol. Occup., 76, 302-307 (1997).
30. Wing E. J., Young J. B., Infect. Immun., 28, 771-776 (1980).
31. Wing E. J., Stanko R. T., Winkelstein A., Adibi S. A., Am. J. Med., 75, 91-96 (1983).
32. Trollmo C., Verdrengh M., Tarkowski A., Ann. Rheum. Dis., 56, 130-134 (1997).
33. Stillings M., Havlik I., Chetty M., Clinton C., Schall R., Moodley I., Muir N., Little S., Curr. Med. Res. Opin., 16, 115-124 (2000).
34. Divoll M., Greenblatt D. J., Ameer B., Abernethy D. R., J. Clin. Pharmacol., 22, 571-576 (1982).
35. Blazka M. E., Wilmer J. L., Holladay S. D., Wilson R. E., Luster M. I., Toxicol. Appl. Pharmacol., 133, 43-52 (1995).
36. Goldin R. D., Ratnayaka I. D., Breach C. S., Brown I. N., Wickramasinghe S. N., J Pathol., 179, 432-435 (1996).
37. Gardner C. R., Heck D. E., Yang C. S., Thomas P. E., Zhang X. J., De-George G. L., Laskin J. D., Laskin D. L., Hepatology, 27, 748-754 (1998).
38. Braun L., Mead J. E., Panzica M., Mikumo R., Bell G. I., Fausto N., Proc. Natl. Acad. Sci. U.S.A., 85, 1539-1543 (1988).
39. Annoni G., Weiner F. R., Zern M. A., J. Hepatol., 14, 259-264 (1992).
40. Delaney B., Strom S. C., Collins S., Kaminski N. E., Toxicol. Appl. Pharmacol., 126, 98-107 (1994).
41. Coffman R. L., Weissman I. L., Nature (London), 289, 681-683 (1981).
42. Renno T., Attinger A., Rimoldi D., Hahne M., Tschopp J., MacDonald H. R., Eur. J. Immunol., 28, 540-547 (1998).
43. Watanabe Y., Akaike T., Scand. J. Immunol., 39, 419-425 (1994).
44. Oka S., Kubo K., Matsuyama S., Takamori Y., J. Vet. Med. Sci., 61, 337-341 (1999).